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a b s t r a c t
Porcine proliferative ileitis is a major economic burden for the swine industry, affecting growing pigs and
young adult pigs. In this study, the protective efficacy of an inactivated, injectable whole-cell bacteria
vaccine against L. intracellularis – Porcilis Ileitis was evaluated under field conditions.
Eighty-five, three-week-old pigs on a commercial farrow-to-finish farm were vaccinated by the intra-
muscular route, either with a dose of injectable vaccine, or with saline. A subset of vaccinates and control
pigs were necropsied at 21 days post-challenge. Incidence and severity of ileitis were evaluated by gross
and microscopic observation of ileal tissues. Colonization of the gut after challenge was examined by
L. intracellularis-specific immunohistochemistry, and qPCR of ileal scrapings. Integrity of the intestinal
barrier was evaluated to quantify a range of intestinal markers including secreted mucin and intestinal
alkaline phosphatase, and innate immune markers including Caspase-3 and Calprotectin. A second subset
of pigs was monitored for fecal shedding of L. intracellularis, until resolution of shedding.
Our investigation indicated that Porcilis Ileitis provided robust protection against ileitis, reduced bac-
terial shedding 15-fold (p < .05) and preserved normal gut barrier function in the face of an experimental
challenge with virulent L. intracellularis.
 2017 Published by Elsevier Ltd.
1. Introduction
Ileitis caused by Lawsonia intracellularis (L. intracellularis) con-
tinues to be a problem in swine production systems worldwide.
L. intracellularis is a Gram-negative, intracellular bacterium that
can infect a number of animal species, but it is of particular eco-
nomic concern in the swine industry. In pigs, the bacteria cause
porcine proliferative enteropathy (ileitis). Clinically affected ani-
mals exhibit diarrhea and reduced growth performance, resulting
in increased time to market and greater variation in size between
pigs. In young adults, the infection can lead to an acute hemor-
rhagic form of the disease, characterized by dark, tarry diarrhea
and which may result in death. L. intracellularis also infects pigs
sub-clinically, without clear clinical signs but still resulting in
reduced growth performance. Its worldwide distribution and high
prevalence have been recognized since the initial characterization
of this pathogen in the early 1990s and L. intracellularis is reported
to affect 57–100% of herds, globally [1–3].
As an obligate intracellular pathogen, interaction between
L. intracellularis and host cells is crucial in establishing infection.
The bacterium infects the gastrointestinal tract, with a specific
tropism for the terminal ileum. The hallmark lesion of L. intracellu-
laris infection is the proliferation of intestinal crypt lining cells
(enterocytes) which results in hyperplasia of the mucosal wall.
The peak of bacterial burden is associated not only with crypt
epithelial cell proliferation but also with down-regulation of speci-
fic host mechanisms involved in cell transport and maintenance of
mucosal integrity, and with inflammation [4–6]. It is likely that the
poor performance and growth of affected animals are a direct
consequence of these cell differentiation alterations [7].
There are some tools available for controlling L. intracellularis
infections and limiting the associated economic losses. Infection
by the bacterium can be treated with various antibiotics, notably
those from the macrolide, pleuromutilin, and quinoxaline groups
[7]. For prophylaxis, a modified live-attenuated vaccine has been
commercially available since 2001 [8]. Due to the live nature of
the oral vaccine, concurrent use with antibiotics effective against
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L. intracellularis is not possible. The use of the oral vaccine requires
strict management practices to avoid the simultaneous use of
antibiotic treatments. However, prophylactic use of an inactivated
vaccine would not be limited in this way.
In this study, the effectiveness of a novel inactivated injectable
vaccine, Porcilis Ileitis, as an aid in the control of ileitis caused by
L. intracellularis was examined. This vaccine was administered to
three-week-old pigs under typical field conditions, without
restricting the use of antibiotics. Our investigation indicates that
Porcilis Ileitis vaccine can provide robust protection against ileitis,
help reduce bacterial shedding 15-fold (p < .01), and help maintain
gut barrier function integrity.
2. Materials and methods
2.1. Ethical statement
The animal trial was conducted by Swine Services Unlimited
(Rice, MN, USA, SSUI) as a randomized, blinded study, approved
by the SSUI Institutional Animal Care and Use Committee.
2.2. Vaccine
The vaccine used in this study contained inactivated L. intracel-
lularis bacteria in XSOLVE adjuvant (Porcilis Ileitis, serial
02381108, Merck Animal Health, Madison, NJ USA). The vaccine
is an oil-in-water emulsion. The adjuvant is based on both mineral
oil and alpha tocopherol (Vitamin E).
2.3. Study design
Eighty-five mixed-breed and mixed-sex pigs were enrolled on a
commercial, farrow-to-finish farm, which farrowed 30 litters per
week, weaning 300 pigs per week. The herd was health-stable prior
to and during the study, with historic pre-weaning mortality rates
between 8 and 10% during the previous 2 years, and nursery mor-
tality of approximately 3%. The herd did not show clinical signs of
L. intracellularis infection, and all study pigs were negative for anti-
L. intracellularis antibodies as measured by a commercial inhibition
ELISA (bioScreen Ileitis Antibody ELISA, Svanova, Sweden).
The study design is summarized in Fig. 1. Pigs were allocated to
the treatments using a random number generator, so that both
vaccinates and placebo injected controls were represented within
all litters. At 22–25 days of age (23 days median), 40 pigs were
given a single 2 mL vaccination intramuscularly in the neck, using
a 20 gauge, ¾ in. needle. Another 40 pigs were injected with 2 mL
of normal saline as a control. Five pigs were allocated to a sentinel
group, and these pigs were administered normal saline in the same
manner as the control pigs.
The pigs were weaned one day after their vaccination. Upon
weaning, the pigs were transported to isolation facilities for the
pre-challenge and challenge phases of the study. Pigs from each
group were comingled with approximately equal numbers of vac-
cinates and controls in each pen.
Prior to the challenge, the treatment groups were divided ran-
domly into a subset of 25 pigs to be necropsied at 21 days post-
challenge (dpc) (necropsy groups), and a subset of 15 pigs to be
fecal sampled to determine L. intracellularis shedding during the
post-challenge period (sampling groups, see Fig. 1). Randomiza-
tions were performed using the Microsoft Excel function Rand()
[9]. Challenge occurred five weeks post-vaccination, when the pigs
were approximately 8 weeks of age. The timing of necropsy was
chosen based on published results of experimental infections
[7,10] and coincided with the peak time of fecal shedding and ileal
lesions found in preliminary experiments with this challenge
model (data not shown).
Prior to the start of the study, as well as prior to the challenge,
all pigs were bled and sera were prepared. Pigs were bled again at
the end of the test, at 21 dpc for the necropsy groups and at 51 dpc
for the shedding groups.
2.4. Husbandry
Water was provided ad libitum to all animals. Feed met or
exceeded the minimum nutritional requirements for animals of
this age and complied with standard procedures for the site. Dur-
ing the pre-weaning phase, the piglets had access to the dam’s feed
and water dispensers. Sow feed during this phase was a standard,
non-medicated lactation diet. Feed was medicated with Mecadox
(carbadox) at 50 g/ton, from the day after the vaccination when
the pigs were weaned, until two weeks later (14 dpv). Carbadox
is a quinoxaline antibiotic indicated for the control of swine dysen-
tery and control of bacterial swine enteritis caused by Salmonella
choleraesuis, but also effective against L. intracellularis, with a
reported intracellular minimum inhibitory concentration of <0.5
mg/mL [11,12]. Three weeks after weaning, mild loose stools were
observed in some of the pens. All pigs were therefore treated for
three days with gentamicin between 22 and 24 dpv. This medica-
tion was administered through the water supply, at 1 mg/pig/day.
Two pigs were removed from the study at 9 and 12 dpv due to
head-tilt and ataxia. Both pigs were allocated in the vaccinated
necropsy group. Diagnostic work-ups resulted in diagnoses of bac-
terial meningitis and possible otitis media, considered unrelated to
the vaccination.
2.5. Challenge
2.5.1. Challenge material
At the time of challenge, the five sentinel pigs were necropsied
and evaluated for evidence of L. intracellularis exposure as detailed
in Section 2.8 Necropsy. The remaining 80 pigs were individually
orally challenged by syringe into the back of the mouth with 25
mL of L. intracellularis-infected gut homogenate, containing
approximately 9.3 Log10 of L. intracellularis, as determined by qPCR.
The gut homogenate was prepared from intestines of pigs experi-
mentally challenged with a virulent isolate obtained in 2008 from
pigs in the United States displaying clinical signs of ileitis. Briefly,
mucosa from guts of pigs with clinical signs of ileitis were collected
by scraping, diluted in sucrose-phosphate-glutamate buffer,
Fig. 1. Study design. Read this figure in conjunction with supplementary Table 1
and the materials and methods section.
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homogenized in a warren blender, trypsinized, aliquoted and fro-
zen at 70 C essentially as described previously [13].
2.5.2. Scoring of clinical signs of ileitis
Following the challenge, all pigs were observed daily for clinical
signs of ileitis, including body condition, alertness, appetite, and
consistency of the feces. Fecal consistency was scored as normal,
soft or watery (mild diarrhea), bloody or tarry (severe diarrhea).
2.6. Serology
Five to 10 mL blood was collected in serum separator tubes, and
centrifuged as recommended by the manufacturer, usually for 20
min at 860g. Sera were collected and stored frozen at 20 C or
lower until testing by a commercial competitive ELISA as docu-
mented in Section 2.3 [14]. Results are reported as percent (%) inhi-
bition. Per the manufacturer’s instructions, results below 20% are
negative for L. intracellularis antibodies, between 20 and 30% are
considered suspect, and 30% and higher indicate positive results.
2.7. Quantitative real-time PCR
Quantitative real-time PCR (qPCR) of ileal scrapings and fecal
samples was conducted at the Iowa State University Veterinary
Diagnostic Laboratory, according to previous standard methods
[15]. Briefly, the region (nucleotide 583–680) of the 16S rDNA gene
of L. intracellularis (GenBank accession # L157390) was monitored
with the forward primer, 50-GCGCGCGTAGGTGGTTATAT-30, the
reverse primer, 50-GCCACCCTCTCCGATACTCA-30 and the fluores-
cent probe 50-FAM-CACCGCTTAACGGTGGAACAGCCTT-TAMRA-30.
The qPCR conditions were as described previously [15]. Results
(Ct values) were reported as the cycle number where fluorescence
exceeded the threshold value. All assays continued for 40 cycles. In
order to calculate the amount of L. intracellularis present in the
samples and to evaluate the treatment effect, Ct values were trans-
formed to copies per reaction (c/rx) by assuming that 40 Ct repre-
sents absence of L. intracellularis DNA (0 c/rx), and assuming 100%
efficiency of replication, resulting in a 10-fold increase of DNA for
every 3.3 cycles reduction in Ct values. Calculations were therefore
carried out as follows: c/rx = 2 ^ (40-Ct).
2.8. Necropsy
The sentinel pigs were necropsied at the time of the challenge,
while the necropsy groups were sacrificed at 21 dpc. In each case,
the ileum was opened longitudinally, and gross lesions of ileitis
were scored. Mucosa were scraped using a glass slide into a 50
mL conical tube, and the collected material was snap-frozen on
dry ice and stored at 70 C until further processing such as the
determination of the level of L. intracellularis in intestinal epithelial
cells as measured by qPCR. Furthermore a tissue sample was fixed
in buffered neutral formalin for microscopic evaluations as
described below.
2.8.1. Gross lesion scoring
Gross lesions were scored on the basis of the severity of muco-
sal thickening (0- normal, 1- slight edema/hyperemia, 2- moderate
hyperemia/mucosal thickening, 3- severe mucosal thickening, 4-
severe hemorrhaging/necrosis/fibrinous exudate). Scores 2–4 were
considered indicative of clinical ileitis.
2.8.2. Histopathology for L. intracellularis
Formalin-fixed tissues were submitted to the Iowa State
University Veterinary Diagnostic Laboratory for standard
histopathological examination following Haematoxylin-Eosin
(H&E) staining to evaluate microscopic lesions, mainly prolifera-
tion, consistent with L. intracellularis (0- no lesions; 1- mild prolif-
eration; 2- marked proliferative enterocolitis).
2.8.3. PAS staining
For PAS staining, fixed tissues were deparaffinized and rehy-
drated, immersed in periodic acid and stained with Schiff’s reagent
as described previously [6].
2.8.4. Immunofluorescence
For immunofluorescence (IF) all the antibodies tested (Supple-
mentary Table 1) except for anti-L. intracellularis antibody required
heat-mediated antigen retrieval in citrate buffer at pH6, using a
Histo5 Rapid Microwave Histoprocessor (Milestone) with the fol-
lowing protocol: high pressure treatment at 110 C for 5 min (20
Fig. 2. Gross lesion and histopathology scoring. (A) A subset of pigs was necropsied
at 21 dpc. The ileum was removed and the mucosa was exposed, then scored on an
ordinal scale (0–4) for increasing severity of gross lesions of ileitis, mainly mucosal
thickening, hyperemia and fibrinous exudate. Scores 2, 3 and 4 were indicative for
ileitis. The incidence of gross lesions of ileitis in the vaccinated group was
significantly reduced compared to the control group (p < .0001). (B) Histopathology
was performed on fixed ileum tissues from the pigs necropsied at 21 dpc. Tissues
were scored on an ordinal scale (0–2) for increasing severity of histological lesions
of ileitis. Scores larger than 0 were indicative for ileitis. The incidence of
microscopic lesions of ileitis in the vaccinated group was significantly reduced
compared to the control group (p = .0018).
F. Roerink et al. / Vaccine xxx (2018) xxx–xxx 3
Please cite this article in press as: Roerink F et al. A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity,
reduction of bacterial shedding and provides robust gut barrier function. Vaccine (2018), https://doi.org/10.1016/j.vaccine.2017.12.049
slides per sample). For L. intracellularis immunostaining, sections
were incubated in proteinase K (DAKO UK Ltd., Ely, UK) for 10
min at room temperature, followed by two washes in phosphate
buffered saline (PBS). Solutions of 0.10% Triton-X in PBS and
0.010% Triton-X in PBS were used to permeabilize the tissue for
10 min at room temperature.
All IF slides were incubated in 5% bovine serum albumin (BSA) in
PBS at room temperature for 30 min. Excess blocking solution was
removed and slides were incubated overnight at 4 C with primary
antibodies in 1% BSA/PBS at the dilutions stated in Supplementary
Table 1. Negative controls were subjected to the same procedures
but with no primary antibodies. Isotype antibody controls for the
primary antibody for 5 sentinels and representative subsets of 3
controls and 3 vaccinates were also conducted (Supplementary
data 1). Slides were washed twice in PBS before a one hour
incubation at room temperature with secondary antibodies Alexa-
Fluor-647 goat anti-rabbit (1:1000, Thermo Fisher Scientific) or
Alexa-488 isothiocyanate (FITC)-conjugated goat anti-mouse
Immunoglobulin G (IgG) (Fc specific) F(ab)2 fragment (1:1000,
Sigma-Aldrich) diluted in 1% BSA/PBS. Slides were washed twice
in PBS then counterstained with 6-diamidino-2-phenylindone
(DAPI, 1:1000 in water, Thermo Fisher Scientific) at room tempera-
ture for 30 min. Slides were again washed twice in PBS and were
finally mounted with Lab Vision PermaFluor aqueous mounting
medium (Thermo Fisher Scientific).
Intestinal alkaline phosphatase (IAP) was monitored with
Vector Red Alkaline Phosphatase Substrate (Vector Laboratories,
Cat. No. SK-5100) according to manufacturer instructions. Slides
were stained with DAPI and mounted as described above. The
presence of intestinal alkaline phosphatasewas viewedwith a Texas
Red filter.
All sections were observed using LSM700 confocal laser scan-
ning microscope (Carl Zeiss) and 2–4 images per sections were
captured and processed blind by a single operator using Zen Blue
software (Carl Zeiss).
2.8.5. Quantitative image analysis
For quantitative analysis of PAS staining for Fig. 6, images were
acquired at 20 magnification from at least three random fields
per condition (Sentinels, Controls, Vaccinates) and processed using
Image J 1.49S as described previously [6,16]. Briefly, the green
channel was selected and the intensity threshold was adjusted to
highlight goblet cells. Crypts were manually outlined and PAS sig-
nal was measured using the purple channel for four to six crypts
per section and signal intensity was normalized to the section area.
For quantitative assessment of IF signals of Fig. 6, confocal images
at 40 magnification were stained with appropriate antibody and
recommended secondary fluorescent antibody (Supplementary
Table 1). For L. intracellularis and Mucin 2 (MUC2), two to four ran-
dom fields from each staining were analyzed using Image J 1.49S.
Briefly, the spectrally opposite color channelwas selectedand inten-
sity thresholdwas adjusted tohighlight themarker.Next, the appro-
priate color channel (green or purple) was selected, and signal
intensity was normalized to the field area and recorded. For cleaved
caspase-3 (CASP3) and Calprotectin (CP), and also for IAP, signal
intensity was normalized to the section area and then recorded.
2.9. Statistical analysis
Statistical analysis for the bacterial shedding data using qPCR,
serological results and quantitative image analysis were carried
out using 1-way ANOVA used after assessing normality of the data
using SAS package with a = 0.05 [17]. Incidence data comparing
the two treatments were analyzed by Fisher’s exact test (GraphPad
Quickcalcs, http://www.graphpad.com/quickcalcs/). qPCR results
were evaluated by the Mann-Whitney test (Minitab v 17). Scatter-
plots were generated using GraphPad Prism v 7.02.
Fig. 3. Quantification of L. intracellularis infection using qPCR and immunofluores-
cence. (A) qPCR was conducted to determine the amount of L. intracellularis DNA in
mucosal scrapings collected at 21 days post challenge. qPCR results were reported
as threshold cycle numbers (Ct) and were converted to copies per reaction (c/rx) as
described in the text. Assays were concluded after 40 cycles. Group mean values are
shown, and p-values when p < .05. (B) H&E and IF detection of L. intracellularis
bacteria. H&E and IF assays were conducted in a blinded fashion on parallel
sections. IF results using monoclonal VPM53 antibody, showing L. intracellularis
bacteria (LI) in representative sentinel, control and vaccinate ileum samples 21 dpc.
The presence of anti L. intracellularis antibodies (VPM53) was detected using FITC-
conjugated secondary antibodies (green). Nuclei were counterstained with DAPI
(Blue). Red box in H&E represents the same location on parallel section used to
detect L. intracellularis bacterium. Scale bar (red line): 50 mm for H&E and 20 mm for
LI. Signal intensity was determined as described in materials and methods section.
(C) Scatterplot of L. intracellularis staining signal intensity obtained using Image J
software for sentinel, control and vaccinate pig ileum crypts at 21 dpc. For
statistical analysis between groups a 1-way ANOVA was used. Group medians are
shown, and p-values where statistically significant differences were found (p < .05).
Y-axis represents fluorescence signal intensity of L. intracellularis antigen staining
per section. (For interpretation of the references to color in this figure legend, the
reader is referred to the web version of this article, Supplementary Table 1.)
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3. Results
3.1. Reduction of signs of clinical disease in vaccinated pigs
All pigs were individually observed every other day for three
weeks following vaccination for any evidence of adverse systemic
or injection site reactions. No systemic adverse reactions to the
vaccination were observed. Local injection site reactions were
observed in 10 of 40 (25%) vaccinated animals, ranging in size
between 1  1 cm and 4  4 cm (length width). All local reac-
tions resolved by 19 days post-vaccination (dpv) without
intervention.
Signs of clinical disease were monitored during the challenge
phase of the experiment. Severe diarrhea was observed in 16 of
40 animals in the control group (40%), but not in any of the 40 vac-
cinated animals. In the vaccinated group, 11 of 40 animals (28%)
presented with mild diarrhea at any time during the post-
challenge period. Loss of appetite, lethargy or ill thrift was
recorded for four control pigs.
Ileum gross lesion scoring is summarized in Fig. 2A. In the con-
trol group, 17 of 25 pigs (68%) were scored as positive (score >1),
whereas only 2 of the 23 vaccinated pigs (9%) were scored as pos-
itive. Seven of the 25 control animals (28%) were given a score of 3
or 4, indicating severe ileitis, while none of the vaccinated pigs had
scores higher than 2. The incidence of gross lesions of ileitis in the
vaccinated group was significantly reduced compared to the con-
trol group (p < .0001).
The occurrence of clinical ileitis was also evaluated by
histopathological examination, on an ordinal scale 0–2 (Fig. 2B).
Of the 25 controls, 22 (88%) were positive (score >0), with 3 pigs
presenting with score 1 and 19 pigs with score 2. Of the vaccinated
group, 10 of 23 (43%) were positive for microscopic lesions. Overall
the incidence of microscopic lesions of ileitis in the vaccinated
group was significantly reduced compared to the control group
(p = .0018).
3.2. Reduction of bacterial load in ileum of vaccinated pigs
Colonization of the small intestines was evaluated in the
necropsy group at 21 dpc by qPCR of the ileal scrapings and
L. intracellularis-specific IF. Results are shown in Fig. 3. All animals
were positive by qPCR on ileal scrapings (Fig. 3A); however, the
average L. intracellularis DNA load of vaccinated pigs was
significantly lower than that of the control pigs (geometric mean
titer GMT: 5.0  104 vs 1.1  107 c/rx, p < .0001). Using IF of
L. intracellularis specific antigen VPM53, intestinal crypt cells of
controls harbored significantly greater bacterial load associated
with enhanced cell proliferation than vaccinated pigs (p < .001)
(Fig. 3B and C).
3.3. Vaccination induces anti-L. Intracellularis serum antibodies
Vaccinated and control pigs were monitored for anti-L.
intracellularis serological profiles using an inhibition assay
(Fig. 4). Vaccinated pigs harbored significantly higher levels of
anti-L. intracellularis antibodies prior to challenge than controls
(p < .0001). Following challenge, all control pigs developed anti-L.
intracellularis antibodies similar to vaccinated pigs as monitored
at 21 and 51 dpc (p > .05).
3.4. Gut integrity is maintained in vaccinates
To assess the integrity of the ileum tissues collected at 21 dpc, a
range of intestinal cell lineage markers was evaluated and quanti-
fied. In particular, molecular markers that identify secretion (PAS
signal and Mucin2, MUC2), absorption and homeostasis (Intestinal
alkaline phosphatase, IAP), apoptosis (Cleaved-caspase3, CASP3)
and immune cell distribution (Calprotectin, CP) were monitored
(Figs. 5 and 6) [6,16,18–20]. In the vaccinated group (n = 23) the
level of PAS, MUC2 as well as IAP was significantly higher than con-
trols (n = 25; p < .01, p < .01, p < .001, respectively). IAP expression in
vaccinated pigs was similar to the level found in the sentinels
(n = 5; p > .05). Expression of apoptotic marker CASP3 was
significantly up-regulated in controls (p < .05) pigs compared to
the sentinels. CP, a marker associated with neutrophil infiltration,
was expressed at a higher level compared to the sentinels, in both
controls (p > .05) and vaccinates (p < .05).
3.5. Fifteen-fold reduction of L. intracellularis fecal shedding in
vaccinates
Fecal shedding was monitored in a subset of the vaccinated
(n = 15) and control (n = 15) animals using qPCR over 51 dpc
(Fig. 7A). The mean daily average amount of L. intracellularis shed
during the 51 dpc was 6.2  105 copies/reaction/day for the control
group, and 4.1  104 per day for the test vaccine animals,
Fig. 4. Antibody titers against L. intracellularis following vaccination and challenge. Group mean anti-L. intracellularis antibody levels were measured using an inhibition
ELISA. Values lower than 30% inhibition are considered suspect or negative. The sentinels were removed at the time of the challenge, which took place at 5 weeks after the
vaccinations. Group mean values and standard deviations are shown. Dpv: days post-vaccination, dpc: days post-challenge.
F. Roerink et al. / Vaccine xxx (2018) xxx–xxx 5
Please cite this article in press as: Roerink F et al. A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity,
reduction of bacterial shedding and provides robust gut barrier function. Vaccine (2018), https://doi.org/10.1016/j.vaccine.2017.12.049
representing a 15-fold reduction (p < .05, Fig. 7B). Overall, the med-
ian duration of shedding was significantly reduced in the vacci-
nated group by 4.4 days (p < .05, data not shown). The median
time point where maximum shedding occurred was also earlier
in vaccinates (14 dpc versus 23 dpc), although this difference was
not statistically significant (p > .05).
4. Discussion
In this study, we have assessed the efficacy of a novel
inactivated, injectable whole-cell bacteria vaccine against
L. intracellularis – Porcilis Ileitis. We found that this adjuvanted
L. intracellularis vaccine was safe in pigs when administered under
typical field conditions at three weeks of age prior to weaning.
Following challenge, signs of severe clinical ileitis were observed
in 40% of the controls, but not in the vaccinated pigs. Protection
of vaccinates was further confirmed by gross observation of the
ileum, as well as histopathology. For each of these parameters, sig-
nificantly more control animals were affected than vaccinated ani-
mals. Taken together these results indicate that the vaccine
reduced both the incidence and severity of clinical signs.
At the time of vaccination nearly all of the animals tested neg-
ative for anti-L. intracellularis antibodies by ELISA, although three
of 85 pigs had test results which were classified as ‘suspect’ by
the manufacturer’s criteria, most likely as a result of low levels of
maternally-derived antibodies against L. intracellularis. The ‘sus-
pect’ animals were included in the analyses. Vaccinated pigs dis-
played an antibody response in the majority of pigs, in spite of
the vaccine regimen consisting of only a single dose. At three
weeks post-vaccination, 75% of vaccinates were classified as sus-
pect or positive. No apparent correlations were found between
sero-response following vaccination and outcome parameters of
the challenge, such as clinical signs, gross lesions, microscopic
scores or PCR results (data not shown). This suggests that at least
part of the protective mechanism of this inactivated, parenteral
vaccine may be through induction of cell-mediated immunity
(CMI) as previously described for other bacterial pathogens, such
as Mycoplasma hyopneumoniae [21–23]. Further investigation is
required to assess if this is the case.
Our study clearly showed that reduced clinical signs in vacci-
nates coincided with a reduced bacterial load and increased ileum
integrity at 21 dpc, compared to nonvaccinated controls. The bac-
terial load was significantly (200-fold) reduced in the terminal
ileum as determined by qPCR, and was significantly lower when
examined by L. intracellularis-specific IF. Bacterial loads were also
significantly lower in the feces of vaccinated animals, both in terms
of reduced severity (bacteria shed per day) and in reduction of the
duration of fecal shedding. Reduced proliferation of enterocytes in
vaccinated pigs compared to controls, as demonstrated by H&E
staining of ileum tissues, coincided with significantly greater num-
bers of MUC2-expressing goblet cells and IAP-expressing brush
border cells than controls indicating a restoration of these essential
intestinal cell lineages [6,16,18–20]. Similarly, the level of cleaved-
CASP3 in lumen of the ileum of vaccinated pigs was, at least in part,
reduced to the level observed in sentinel pigs. This may indicate a
possible reduction in apoptosis mechanisms as previously
described [16]. In contrast, we found that the induction of CP, a
marker of neutrophil and macrophage infiltration, was still notice-
ably expressed in the ileum of vaccinated pigs, perhaps indicating
that innate immune cells were actively patrolling the lamina pro-
pria at 21 dpc [24]. Taken together, the monitoring of these intesti-
nal cell lineages and immune markers supports an immunization
mechanism whereby the vaccination not only prevented infection
by L. intracellularis of the crypt cells, but also helped preserve near
normal mucosal architecture and homeostasis.
According to Johansen et al. [25], diarrhea is a significant risk
factor for low growth rate in pigs, and a 10-fold increase in fecal
load of L. intracellularis increases the odds ratio for low growth rate
by 2. In this study, fecal shed in the vaccinates was reduced 15-fold
compared to the controls. Although this study did not record
growth parameters, the vaccination can be expected to have pre-
vented the negative impacts of L. intracellularis infection on the
economic parameters of this cohort of pigs.
The use of a killed Lawsonia vaccine in this study allowed the
administration of antibiotics to the pigs around the time of the vac-
cination. The vaccine was compatible with the use of carbadox
administered in the feed as early as one day after vaccination, as
demonstrated by the protection that was shown against virulent
challenge compared with non-vaccinated control pigs.
In conclusion, the data demonstrated that this inactivated, adju-
vanted L. intracellularis vaccine was safe in pigs when administered
under typical field conditions as a single, 2 mL dose at three weeks
Fig. 5. Assessing intestinal integrity of ileum 21 dpc in sentinel, control and
vaccinate pig groups. Goblet cells were identified using PAS staining. IF was used to
detect mucin-2 (MUC2), intestinal alkaline phosphatase (IAP), cleaved-caspase-3
(CASP3) and calprotectin (CP). Anti-MUC2 and anti-calprotectin antibodies were
detected using Alexa-647-conjugated secondary antibody (purple). Anti-cleaved
Caspase-3 antibody was detected using Alexa-488-conjugated secondary antibody
(green). Intestinal alkaline phosphatase was detected as described in materials and
methods. DAPI (blue) was used to counterstain the nuclei. Scale bar: 20 mM.
Representative images are shown from animals with median results for each
staining method and group. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article.)
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of age prior to weaning. The study demonstrated that the vaccine
reduced both the incidence and severity of clinical signs of ileitis
due to L. intracellularis, reduced colonization by L. intracellularis,
and reduced the severity and duration of fecal shedding of
L. intracellularis. The study also found that gut function in the face
of L. intracellularis infection was improved following vaccination.
Fig. 6. Scatterplot of PAS, IAP and IF signals for MUC2, CASP3 and CP. Scatterplot of staining signal intensities obtained using Image J software for sentinel, control and
vaccinate ileum crypts at 21 dpc. Image quantification was performed as described in materials and methods section. For statistical analysis between groups a 1-way ANOVA
was used as previously described. Group median values and P-values are shown when p < .05. For MUC2 and PAS staining 4 sentinels instead of 5 were used because one
paraffin-block was missing at the time of the staining. Missing pig section was not assessed because of the relatively small spread between data. Y-axis represents
fluorescence signal intensity of the marker staining per section.
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